grepcent public filings, reorganized for comparison

Concentra Group Holdings Parent, Inc. (CON)

CIK: 0002014596. SIC: 8093 Services-Specialty Outpatient Facilities, NEC. Latest 10-K as of: 2026-02-26.

SIC breadcrumb: Services > SIC Major Group 80 > SIC 8093 Services-Specialty Outpatient Facilities, NEC

SEC company page: https://www.sec.gov/edgar/browse/?CIK=2014596. Latest filing source: 0002014596-26-000029.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-26 · accession 0002014596-26-000029 · source: SEC companyfacts

Revenue
2,163,417,000 USD verified
Net income
166,415,000 USD verified
Assets
2,858,388,000 USD verified
Free cash flow
197,062,000 USD computed
Net margin
7.69% computed
Operating margin
15.44% computed
Revenue YoY
+13.85% computed
ROE
42.31% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

CON ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.CON ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.RatioCONPeer medianPercentileNNet margin7.7%3.2%7856Operating margin15.4%5.5%9251Revenue growth13.9%11.8%5757FCF margin9.1%5.4%7448ROE42.3%7.9%9453ROA5.8%2.8%6758Liabilities / equity6.201.139154Current ratio1.141.632658

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 80 SIC Major Group 80, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue2,163,417,000USD20252026-02-26
Net income166,415,000USD20252026-02-26
Assets2,858,388,000USD20252026-02-26

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-26. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0002014596.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2022202320242025
Revenue1,724,359,0001,838,081,0001,900,192,0002,163,417,000
Net income166,727,000179,947,000166,543,000166,415,000
Operating income258,529,000287,632,000304,763,000333,992,000
Diluted EPS1.601.731.461.30
Operating cash flow274,337,000234,316,000274,677,000279,397,000
Capital expenditures45,983,00064,958,00064,327,00082,335,000
Dividends paid0.000.007,959,00032,077,000
Share buybacks0.000.0015,403,00022,423,000
Assets2,297,235,0002,333,560,0002,521,164,0002,858,388,000
Liabilities1,156,121,0002,222,440,0002,437,959,000
Stockholders' equity275,671,000393,281,000
Cash and cash equivalents31,374,000183,255,00079,899,000
Free cash flow228,354,000169,358,000210,350,000197,062,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2022202320242025
Net margin9.67%9.79%8.76%7.69%
Operating margin14.99%15.65%16.04%15.44%
Return on equity60.41%42.31%
Return on assets7.26%7.71%6.61%5.82%
Liabilities / equity8.066.20
Current ratio1.071.421.14

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Free cash flow = operating cash flow - capital expenditures

CON FY2025 free cash flow bridge from reported figures.CON FY2025 free cash flow bridge from reported figures.CON free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$250.0M$500.0M$279.4MOperating cash flow-$82.3MCapex$197.1MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0002014596-26-000029; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0002014596-26-000029; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0002014596-26-000029; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

CON revenue, last 4 periods. Source: SEC companyfacts FY2025.CON revenue, last 4 periods. Source: SEC companyfacts FY2025.CON RevenueLatest point: FY2025 = $2.2BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$2.0B$4.0B$1.7BFY2022$1.8BFY2023$1.9BFY2024$2.2BFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

CON net income, last 4 periods. Source: SEC companyfacts FY2025.CON net income, last 4 periods. Source: SEC companyfacts FY2025.CON Net incomeLatest point: FY2025 = $166.4MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0M$166.7MFY2022$179.9MFY2023$166.5MFY2024$166.4MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

CON operating income, last 4 periods. Source: SEC companyfacts FY2025.CON operating income, last 4 periods. Source: SEC companyfacts FY2025.CON Operating incomeLatest point: FY2025 = $334.0MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$250.0M$500.0M$258.5MFY2022$287.6MFY2023$304.8MFY2024$334.0MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

CON diluted eps, last 4 periods. Source: SEC companyfacts FY2025.CON diluted eps, last 4 periods. Source: SEC companyfacts FY2025.CON Diluted EPSLatest point: FY2025 = $1.30/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$1.00/share$2.00/shareFY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

CON operating cash flow, last 4 periods. Source: SEC companyfacts FY2025.CON operating cash flow, last 4 periods. Source: SEC companyfacts FY2025.CON Operating cash flowLatest point: FY2025 = $279.4MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$250.0M$500.0M$274.3MFY2022$234.3MFY2023$274.7MFY2024$279.4MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

CON capital expenditures, last 4 periods. Source: SEC companyfacts FY2025.CON capital expenditures, last 4 periods. Source: SEC companyfacts FY2025.CON Capital expendituresLatest point: FY2025 = $82.3MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0M$46.0MFY2022$65.0MFY2023$64.3MFY2024$82.3MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

CON dividends paid, last 4 periods. Source: SEC companyfacts FY2025.CON dividends paid, last 4 periods. Source: SEC companyfacts FY2025.CON Dividends paidLatest point: FY2025 = $32.1MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: PaymentsOfDividendsCommonStock. Source concepts: us-gaap:PaymentsOfDividendsCommonStock.

CON share buybacks, last 4 periods. Source: SEC companyfacts FY2025.CON share buybacks, last 4 periods. Source: SEC companyfacts FY2025.CON Share buybacksLatest point: FY2025 = $22.4MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

CON assets, last 4 periods. Source: SEC companyfacts FY2025.CON assets, last 4 periods. Source: SEC companyfacts FY2025.CON AssetsLatest point: FY2025 = $2.9BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$2.0B$4.0B$2.3BFY2022$2.3BFY2023$2.5BFY2024$2.9BFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: Assets. Source concepts: us-gaap:Assets.

CON liabilities, last 3 periods. Source: SEC companyfacts FY2025.CON liabilities, last 3 periods. Source: SEC companyfacts FY2025.CON LiabilitiesLatest point: FY2025 = $2.4BSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$2.0B$4.0B$1.2BFY2023$2.2BFY2024$2.4BFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

CON stockholders' equity, last 2 periods. Source: SEC companyfacts FY2025.CON stockholders' equity, last 2 periods. Source: SEC companyfacts FY2025.CON Stockholders' equityLatest point: FY2025 = $393.3MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$250.0M$500.0M$275.7MFY2024$393.3MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

CON cash and cash equivalents, last 3 periods. Source: SEC companyfacts FY2025.CON cash and cash equivalents, last 3 periods. Source: SEC companyfacts FY2025.CON Cash and cash equivalentsLatest point: FY2025 = $79.9MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0M$31.4MFY2023$183.3MFY2024$79.9MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

CON free cash flow, last 4 periods. Source: SEC companyfacts FY2025.CON free cash flow, last 4 periods. Source: SEC companyfacts FY2025.CON Free cash flowLatest point: FY2025 = $197.1MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0M$228.4MFY2022$169.4MFY2023$210.3MFY2024$197.1MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002014596-26-000029; filed 2026-02-26. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-06. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0002014596.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2024-Q22024-06-30477,915,00053,059,0000.50reported discrete quarter
2024-Q32024-09-30489,638,00045,759,0000.37reported discrete quarter
2024-Q42024-12-31465,041,00022,800,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-31500,752,00040,642,0000.30reported discrete quarter
2025-Q22025-06-30550,785,00046,194,0000.35reported discrete quarter
2025-Q32025-09-30572,800,00049,822,0000.38reported discrete quarter
2025-Q42025-12-31539,080,00036,191,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-31569,555,00052,292,0000.39reported discrete quarter
2026-Q22026-06-30606,030,00067,299,0000.51reported discrete quarter

Quarterly Charts

CON quarterly revenue, last 9 periods. Source: SEC companyfacts 2026-Q2.CON quarterly revenue, last 9 periods. Source: SEC companyfacts 2026-Q2.CON Quarterly RevenueLatest point: 2026-Q2 = $606.0MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$375.0M$750.0M2024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0002014596-26-000056; filed 2026-08-06. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

CON quarterly net income, last 9 periods. Source: SEC companyfacts 2026-Q2.CON quarterly net income, last 9 periods. Source: SEC companyfacts 2026-Q2.CON Quarterly Net incomeLatest point: 2026-Q2 = $67.3MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0002014596-26-000056; filed 2026-08-06. Concept: ProfitLoss. Source concepts: us-gaap:ProfitLoss.

CON quarterly diluted eps, last 7 periods. Source: SEC companyfacts 2026-Q2.CON quarterly diluted eps, last 7 periods. Source: SEC companyfacts 2026-Q2.CON Quarterly Diluted EPSLatest point: 2026-Q2 = $0.51/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$0.50/share$1.00/share2024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0002014596-26-000056; filed 2026-08-06. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read CON's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read CON's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0002014596-26-000056.

Extracted from a substantive MD&A body after the formal Item 2 span was a TOC or reference stub. Confidence: high. Filing date: 2026-08-06. Report date: 2026-06-30.

Overview

We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America’s workforce. As of June 30, 2026, we operated 633 stand-alone occupational health centers in 41 states and 415 onsite health clinics at employer worksites in 44 states. We also have expanded our reach via our telemedicine program serving 43 states and the District of Columbia. In total, we deliver services across 46 states and the District of Columbia. Our patients are generally employed by our main customers — employers across the United States.

Our business is organized into three operating segments based primarily on the type or location of occupational health services provided:

•Occupational health centers: Our occupational health centers operating segment encompasses the services we deliver at our 633 occupational health center facilities across the United States. In this operating segment, we serve all types of employers, from Fortune 100 companies to small businesses. The occupational health services provided in this operating segment include workers’ compensation and employer services, and we also provide consumer health services.

•Onsite health clinics: Our onsite health clinics operating segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services — we deliver our services at 415 permanent on-site locations and multiple other employer locations through our episodic services. In this operating segment, we serve medium to large-sized employers.

•Other businesses: Our other businesses operating segment is comprised of several complementary services to our core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration. In this operating segment, we serve all types of employers.

All three operating segments are aggregated into a single reportable segment in our condensed consolidated financial statements based on similar services provided, service delivery process involved, target customers, and similar economic characteristics.

The following table represents the percentage of revenue by our operating segments for the periods indicated:

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Occupational health centers91%94%91%94%
Onsite health clinics7%4%7%4%
Other businesses2%2%2%2%

Across our operating segments, we offer a diverse and comprehensive array of occupational health services, including workers’ compensation and employer services, and consumer health services:

•Workers’ compensation services: include the support of workers’ compensation injuries and illnesses, physical rehabilitation, and specialist care.

•Employer services: consist of drug and alcohol screenings, physical examinations and evaluations, clinical testing, and preventive care, as well as direct-to-employer services that include the services described above and advanced primary care at our onsite health clinics.

•Consumer health services: consist of the support of patient-directed urgent care treatment of injuries and illnesses.

26

Table of Contents

The following table sets forth the percentage of our overall visits per day (“VPD”) volume in our occupational health center operating segment by service offering, for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Workers’ compensation services46%45%46%45%
Employer services53%53%52%53%
Consumer health services1%2%2%2%

The following table sets forth the percentage of visit-related revenue in our occupational health center operating segment by service offering, for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Workers’ compensation services66%64%65%64%
Employer services33%34%33%34%
Consumer health services1%2%2%2%

Regulatory Matters

Our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026, contains a detailed discussion of the regulations that affect our business in Part I, Item 1. Business—“Government Regulations”.

27

Table of Contents

Operating Statistics

Management utilizes specific key operating metrics to monitor trends and performance in our business and therefore may be important to investors because management may assess our performance based in part on such metrics. Other healthcare providers may present similar measures; however, these measures are susceptible to varying definitions and our key metrics may not be comparable to other similarly titled measures of other companies.

Patient Visits and VPD Volume

We monitor the number of patient visits and VPD volume for each of our major service lines in our occupational health center operating segment — workers’ compensation services, employer services, and consumer health. Management believes that the number of patient visits is the single most important indicator of the volume of services being provided in our centers. VPD volume, which is calculated as total patient visits in a given period divided by total business days for such period, allows for comparability between time periods with different number of business days. Patient visits and VPD volume include only the patients seen in our occupational health centers operating segment and does not include our onsite health clinics or other businesses operating segments.

Revenue Per Visit

Management also measures reimbursement rates utilizing patient revenue per visit which is calculated as total patient revenue divided by total patient visits for the relevant period. Revenue per visit as reported includes only the revenue and patient visits in our occupational health centers operating segment and does not include our onsite health clinics or other businesses operating segments.

The following table sets forth operating statistics for our occupational health centers operating segment for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
20262025% Change20262025% Change
Number of patient visits
Workers’ compensation1,648,9831,589,9813.7%3,232,3263,034,8616.5%
Employer services1,910,9841,877,3831.8%3,689,5683,573,7953.2%
Consumer health50,96752,956(3.8)%108,131116,032(6.8)%
Total3,610,9343,520,3202.6%7,030,0256,724,6884.5%
VPD volume
Workers’ compensation25,76524,8433.7%25,45123,8976.5%
Employer services29,85929,3341.8%29,05228,1403.2%
Consumer health796827(3.8)%851914(6.8)%
Total56,421(1)55,005(1)2.6%55,355(1)52,950(1)4.5%
Revenue per visit
Workers’ compensation$219.06$208.934.9%$216.22$209.003.5%
Employer services95.8492.853.2%96.3693.593.0%
Consumer health135.26135.52(0.2)%136.16136.060.1%
Total$152.67$145.924.6%$152.08$146.413.9%
Business days6464127127

_________________________________________

(1)    Does not foot due to rounding.

28

Table of Contents

Facility Counts

The following table sets forth facility counts for our occupational health centers and onsite health clinics operating segments for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Number of occupational health centers—start of period632627628552
Number of occupational health centers acquired372
Number of occupational health centers de novos1124
Number of occupational health centers closed
Number of occupational health centers—end of period633628633628
Number of onsite health clinics—end of period415406415406

Results of Operations

The following tables outline selected operating data as a percentage of revenue for the periods indicated:

Three Months Ended June 30,
20262025
($ in thousands)AmountPercent(2)AmountPercent(2)
Revenue$606,030100.0%$550,785100.0%
Costs and expenses:
Cost of services, exclusive of depreciation and amortization413,93368.3389,33470.7
General and administrative, exclusive of depreciation and amortization56,6779.452,9319.6
Depreciation and amortization19,8993.318,9983.4
Total costs and expenses490,50980.9461,26383.7
Other operating (expense) income(453)(0.1)200.0
Income from operations115,06819.089,54216.3
Other income and expense:
Interest expense(25,723)(4.2)(28,193)(5.1)
Income before income taxes89,34514.761,34911.1
Income tax expense22,0463.615,1552.8
Net income67,29911.146,1948.4
Less: net income attributable to non-controlling interests2,0000.31,6340.3
Net income attributable to the Company$65,29910.8%$44,5608.1%
Adjusted EBITDA(1)$140,93423.3%$115,01820.9%
Adjusted Net Income Attributable to the Company(1)$66,68211.0%$47,7178.7%

_________________________________________

(1)    Adjusted EBITDA and Adjusted Net Income Attributable to the Company are financial measures not calculated in accordance with U.S. GAAP. For definitions and reconciliations to the U.S. GAAP measures, refer to “—Non-GAAP Measures”.

(2)    Totals in this column may not foot due to rounding.

29

Table of Contents

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0002014596-26-000029. The complete FY 2025 MD&A is published at /company/CON/mda/fy2025/.

Extracted from a substantive MD&A body after the formal Item 7 span was a TOC or reference stub. Confidence: high. Filing date: 2026-02-26. Report date: 2025-12-31.

Overview

We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America’s workforce. As of December 31, 2025, we operated 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. We also have expanded our reach via our telemedicine program serving 43 states and the District of Columbia. In total, we deliver services across 47 states and the District of Columbia. We had approximately 13,000 colleagues and affiliated physicians and clinicians as of December 31, 2025 who supported the delivery of an extensive suite of services, including occupational and consumer health services and other direct-to-employer care to approximately 53,000 patients each business day on average during 2025. Our patients are generally employed by our main customers — employers across the United States.

Our business is organized into three operating segments based primarily on the type or location of occupational health services provided:

•    Occupational health centers: Our occupational health centers operating segment encompasses the services we deliver at our 628 occupational health center facilities across the United States. In this operating segment, we serve all types of employers, from Fortune 100 companies to small businesses. The occupational health services provided in this operating segment include workers’ compensation and employer services, and we also provide consumer health services.

•    Onsite health clinics: Our onsite health clinics operating segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services — we deliver our services at 411 permanent on-site locations and multiple other employer locations through our episodic services. In this operating segment, we serve medium to large-sized employers.

•    Other businesses: Our other businesses operating segment is comprised of several complementary services to our core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration. In this operating segment, we serve all types of employers.

All three operating segments are aggregated into a single reportable segment in our consolidated financial statements based on similar services provided, service delivery process involved, target customers, and similar economic characteristics.

The following table represents the percentage of revenue by our operating segments for the periods indicated:

Year Ended December 31,
202520242023
Occupational health centers93%95%95%
Onsite health clinics5%3%3%
Other businesses2%2%2%

61

Table of Contents

Across our operating segments, we offer a diverse and comprehensive array of occupational health services, including workers’ compensation, employer services and consumer health services:

•Workers’ compensation services: include the support of workers’ compensation injuries and illnesses, physical rehabilitation, and specialist care.

•Employer services: consist of drug and alcohol screenings, physical examinations and evaluations, clinical testing, and preventive care, as well as direct-to-employer services that include the services described above and advanced primary care at our onsite health clinics.

•Consumer health services: consist of the support of patient-directed urgent care treatment of injuries and illnesses.

The following table sets forth the percentage of our overall visits per day (“VPD”) volume in our occupational health center operating segment by service offering, for the periods presented:

Year Ended December 31,
202520242023
Workers’ compensation services46%46%44%
Employer services52%52%54%
Consumer health services2%2%2%

The following table sets forth the percentage of visit-related revenue in our occupational health center operating segment by service offering, for the periods presented:

Year Ended December 31,
202520242023
Workers’ compensation services65%64%64%
Employer services33%34%34%
Consumer health services2%2%2%

62

Table of Contents

Significant Events

Nova Acquisition

Effective March 1, 2025, the Company acquired Nova. CHSI entered into an equity purchase agreement to acquire all of the outstanding membership interests for a purchase price of $265.0 million, subject to adjustment in accordance with the terms and conditions set forth in the purchase agreement. We financed the transaction using a combination of $102.1 million of new debt financing under the Credit Agreement, $50.0 million of available borrowing capacity under our existing Revolving Credit Facility, and the remaining with cash on hand.

Nova operated 67 occupational health centers in five states, providing workers’ compensation injury care services, physical therapy, drug and alcohol screening, and pre-employment physicals as part of their full suite of occupational health services.

Debt Financing

On March 3, 2025, the Company completed an amendment to the Credit Agreement to increase our Revolving Credit Facility by $50.0 million from $400.0 million to $450.0 million. The interest rate for the Revolving Credit Facility has been reduced from Term SOFR plus 2.50% to Term SOFR plus 2.00%, subject to a leverage-based pricing grid including a 25-basis point step down at a net leverage ratio of ≤3.50x. In addition, the amendment to the Credit Agreement also added new debt through an incremental term loan of $102.1 million, which provides an updated Term Loan of $950.0 million. The Term Loan interest rate has been reduced from Term SOFR plus 2.25% down to Term SOFR plus 2.00%, subject to a leverage-based pricing grid including a 25-basis point step down at a net leverage ratio of ≤3.25x.

Pivot Onsite Innovations Acquisition

Effective June 1, 2025, the Company acquired Pivot Onsite Innovations from Pivot Occupational Health, LLC. CHSI entered into an equity purchase agreement to acquire all of the outstanding equity interests for a purchase price of $54.4 million, subject to adjustment in accordance with the terms and conditions set forth in the purchase agreement. We financed the transaction using a combination of $35.0 million of available borrowing capacity under our existing Revolving Credit Facility and the remaining with cash on hand.

Pivot Onsite Innovations operated over 240 onsite health clinics at employer locations in over 40 states, providing occupational health, wellness, prevention, and performance services. The acquisition enabled the Company to expand to over 400 onsite health clinics at employer worksites.

Voluntary Repayment of Debt

During the year ended December 31, 2025, the Company made voluntary repayments on the Revolving Credit Facility of $85 million, which resulted in no borrowings outstanding on the Revolving Credit Facility as of December 31, 2025. These repayments were made using available cash on hand and were not contractually required. Under the terms of the Credit Agreement, repayment was not due until July 26, 2029.

Repurchase of Common Stock

During the year ended December 31, 2025, we repurchased 1.1 million shares of our common stock for $22.4 million. The repurchase of common stock included shares repurchased under the share repurchase program and 114,052 shares of common stock repurchased for $2.4 million related to the shares withheld in connection with the vesting of employee restricted stock awards. Shares repurchased in connection with employee restricted stock awards do not impact the remaining authorization under the share repurchase program.

Share Repurchase Program

On November 5, 2025, the Board of Directors authorized a share repurchase program to repurchase up to $100 million of the Company’s outstanding common stock. The share repurchase program will expire on December 31, 2027, unless extended or terminated by the Board of Directors. Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as the Board of Directors deems appropriate. The Company will fund the share repurchase program with cash on hand. The authorization of the share repurchase program does not obligate the Company to repurchase any shares.

During the year ended December 31, 2025, the Company repurchased 1.0 million shares of common stock under the share repurchase program for $20.0 million. All shares repurchased were permanently retired. As of December 31, 2025, the Company’s remaining authorization to repurchase shares under the program was $80.0 million.

63

Table of Contents

Operating Statistics

Management utilizes specific key operating metrics to monitor trends and performance in our business and therefore may be important to investors because management may assess our performance based in part on such metrics. Other healthcare providers may present similar measures; however, these measures are susceptible to varying definitions and our key metrics may not be comparable to other similarly titled measures of other companies.

Patient Visits and VPD Volume

We monitor the number of patient visits and VPD volume for each of our major service lines in our occupational health center operating segment — workers’ compensation services, employer services, and consumer health. Management believes that the number of patient visits is the single most important indicator of the volume of services being provided in our centers. VPD volume, which is calculated as total patient visits in a given period divided by total business days for such period, allows for comparability between time periods with different number of business days. Patient visits and VPD volume include only the patients seen in our occupational health centers segment and does not include our onsite health clinics or other businesses operating segments.

Revenue Per Visit

Management also measures reimbursement rates utilizing patient revenue per visit which is calculated as total patient revenue divided by total patient visits for the relevant period. Revenue per visit as reported includes only the revenue and patient visits in our occupational health centers operating segment and does not include our onsite health clinics or other businesses operating segments.

The following table sets forth operating statistics for our occupational health centers operating segment for the periods presented:

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for CON

Indicators mapped to this company's SIC classification (industry 8093 Services-Specialty Outpatient Facilities, NEC) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: US labor market, Growth & output, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/CON.md · JSON record: /company/CON.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt